VIVA BIOTECH(01873),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01873 VIVA BIOTECH

Closed 05-15 16:09:05

1.450

-0.020

-1.36%

High1.470	Low1.400	Vol4.81M
Open1.470	D1 Closing1.470	Amplitude4.76%
Mkt Cap3.09B	Tradable Cap3.09B	Total Shares2.13B
T/O6.91M	T/O Rate0.23%	Tradable Shares2.13B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01873","market":"HK","secType":"STK","nameCN":"VIVA BIOTECH","latestPrice":1.45,"timestamp":1778832545005,"preClose":1.47,"halted":0,"volume":4811000,"delay":0,"changeRate":-0.01360544217687076,"floatShares":2130000000,"shares":2130000000,"eps":0.10343947199473874,"marketStatus":"Closed","change":-0.02,"latestTime":"05-15 16:09:05","open":1.47,"high":1.47,"low":1.4,"amount":6909870,"amplitude":0.047619,"askPrice":1.46,"askSize":80500,"bidPrice":1.45,"bidSize":83000,"shortable":3,"etf":0,"ttmEps":0.13102333119333576,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"listingDate":1557331200000,"exchange":"SEHK","adjPreClose":1.47,"openAndCloseTimeList":[[1778808600000,1778817600000],[1778821200000,1778832000000]],"volumeRatio":0.571235,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01873/wiki","defaultTab":"wiki","newsList":[{"id":"1119618941","title":"Viva Biotech executes fourth consecutive buyback; 1.60 million shares repurchased on 13 May, cumulative May purchases reach 8.48 million shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1119618941","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119618941?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:22","pubTimestamp":1778671368,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings disclosed that on 13 May 2026 it repurchased 1.60 million ordinary shares on the Hong Kong Stock Exchange, paying between HKD 1.50 and HKD 1.52 per share. The transaction cost...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147871639","title":"VIVA BIOTECH (01873) Repurchases 1.6 Million Shares for HK$2.414 Million on May 13","url":"https://stock-news.laohu8.com/highlight/detail?id=1147871639","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147871639?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:16","pubTimestamp":1778670986,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) announced that on May 13, 2026, the company repurchased 1.6 million shares at a total cost of HK$2.414 million.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","01873","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635786082","title":"VIVA Biotech files HKEX next-day return, discloses share buyback at HKD 1.51","url":"https://stock-news.laohu8.com/highlight/detail?id=2635786082","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635786082?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:13","pubTimestamp":1778670829,"startTime":"0","endTime":"0","summary":"VIVA Biotech repurchased 1.6 million shares on May 13 for cancellation.Buyback price range HKD 1.5 to HKD 1.52 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VIVA Biotech Holdings published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL8vQ9Rp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128408966","title":"VIVA BIOTECH Announces Share Buyback Transaction on May 12","url":"https://stock-news.laohu8.com/highlight/detail?id=1128408966","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128408966?lang=en_us&edition=fundamental","pubTime":"2026-05-12 17:58","pubTimestamp":1778579894,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) has announced a share repurchase. On May 12, 2026, the company utilized HK$2.3914 million to buy back 1.527 million shares. The repurchase price ranged from HK$1.56 to HK$1.58 per share.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","01873","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634292900","title":"VIVA Biotech files HKEX next-day return, discloses share buyback at HKD 1.57 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2634292900","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634292900?lang=en_us&edition=fundamental","pubTime":"2026-05-12 17:55","pubTimestamp":1778579702,"startTime":"0","endTime":"0","summary":"Viva Biotech filed next-day disclosure return showing repurchase of 1,527,000 shares on 12 May 2026.Buyback executed on HKEX at HKD 1.56-1.58 per share, HKD 2.39 million aggregate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VIVA Biotech Holdings published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL9VNwfl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873","BK1141","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159299013","title":"VIVA BIOTECH (01873) Invests HK$6.47 Million in Share Buyback on May 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1159299013","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159299013?lang=en_us&edition=fundamental","pubTime":"2026-05-11 16:37","pubTimestamp":1778488625,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) announced that on May 8, 2026, the company executed a share repurchase, spending HK$6.47 million to acquire 4.164 million shares.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","01873","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634409343","title":"VIVA Biotech files HKEX return, repurchases shares at HKD 1.55 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2634409343","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634409343?lang=en_us&edition=fundamental","pubTime":"2026-05-11 16:31","pubTimestamp":1778488310,"startTime":"0","endTime":"0","summary":"VIVA Biotech repurchased 4,164,000 ordinary shares on May 8.Buyback price range HKD 1.52 to HKD 1.59 per share; aggregate consideration HKD 6.47 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VIVA Biotech Holdings published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 11, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL3gpcW6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148224752","title":"VIVA BIOTECH (01873) Repurchases 4.164 Million Shares for HK$6.4714 Million on May 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1148224752","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148224752?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:38","pubTimestamp":1778243901,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) announced that on May 8, 2026, the company repurchased 4.164 million shares at a cost of HK$6.4714 million.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","BK1141","01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633456257","title":"VIVA Biotech files HKEX return, repurchases shares at HKD 1.55 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2633456257","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633456257?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:30","pubTimestamp":1778243416,"startTime":"0","endTime":"0","summary":"VIVA Biotech repurchased 4,164,000 shares on May 8 at HKD 1.52 to HKD 1.59 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VIVA Biotech Holdings published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL1Pygr5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1576","01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155519546","title":"Viva Biotech Reports Stable Share Capital and Public Float Compliance for April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1155519546","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155519546?lang=en_us&edition=fundamental","pubTime":"2026-05-07 11:03","pubTimestamp":1778123004,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings (Viva Biotech) filed its monthly return for April 2026, confirming that no changes occurred in either authorised or issued share capital during the period. Authorised capital...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631757146","title":"Viva Biotech Holdings' (HKG:1873) Profits May Not Reveal Underlying Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2631757146","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631757146?lang=en_us&edition=fundamental","pubTime":"2026-04-30 06:29","pubTimestamp":1777501756,"startTime":"0","endTime":"0","summary":"The stock price didn't jump after Viva Biotech Holdings ( HKG:1873 ) posted decent earnings last week. We think that...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1873/viva-biotech-holdings-shares/news/viva-biotech-holdings-hkg1873-profits-may-not-reveal-underly","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1873/viva-biotech-holdings-shares/news/viva-biotech-holdings-hkg1873-profits-may-not-reveal-underly","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1141","BK4121","BK4585","XBI","01873","VBIZF","BK4588","BK4581","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112185487","title":"VIVA BIOTECH's Shares Nearly Halved in Three Months, Lagging Behind CXO Sector's Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1112185487","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112185487?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:15","pubTimestamp":1777281318,"startTime":"0","endTime":"0","summary":"Following a rebound to a阶段性 high of HK$2.86 in late January, VIVA BIOTECH's (01873) stock price has experienced a nearly three-month decline. It was observed that on April 27, the stock hit an...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CXO","BK1141","BK1576","01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175975437","title":"VIVA BIOTECH 2025 ESG Report: Net Profit Up 21.30%, Carbon Emissions Cut 6%, AI-Driven Drug Discovery Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=1175975437","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175975437?lang=en_us&edition=fundamental","pubTime":"2026-04-22 18:23","pubTimestamp":1776853404,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH released its seventh ESG report, detailing 2025 operating and sustainability results. Financial Performance   • Revenue grew 21.31% year-on-year to RMB 1.73 billion.   • Net profit...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101767873","title":"维亚生物2025年净利同比增至人民币2.693亿元，CRO与CDMO业务双线发力","url":"https://stock-news.laohu8.com/highlight/detail?id=1101767873","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101767873?lang=en_us&edition=fundamental","pubTime":"2026-04-22 17:11","pubTimestamp":1776849081,"startTime":"0","endTime":"0","summary":"维亚生物在其截至2025年12月31日止年度的业绩报告中显示，期内收入为人民币17.294亿元（2024年：19.867亿元），同比下降12.9%。尽管营收下滑，全年净利润依然从上年的2.220亿元增长至2.693亿元，同比上升21.3%。同期毛利为6.556亿元，毛利率由34.6%提升至37.9%，反映出更有效的成本管控与业务组合优化。公司经调整后（非IFRS）净利润从3.146亿元增加至3.3...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维亚生物2025年净利同比增至人民币2.693亿元，CRO与CDMO业务双线发力","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148827036","title":"Viva Biotech calls 26 June 2026 AGM; proposes 20 % share-issue mandate, 10 % buy-back limit and re-election of three directors","url":"https://stock-news.laohu8.com/highlight/detail?id=1148827036","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148827036?lang=en_us&edition=fundamental","pubTime":"2026-04-22 17:05","pubTimestamp":1776848709,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings will hold its annual general meeting on 26 June 2026 at 10:00 a.m. (Meeting Room A615, 735 Ziping Road, Zhoupu Town, Pudong New District, Shanghai). Key resolutions to be put to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629101541","title":"VIVA Biotech Holdings announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629101541","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629101541?lang=en_us&edition=fundamental","pubTime":"2026-04-22 16:39","pubTimestamp":1776847142,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings will hold annual general meeting in Shanghai on June 26, 2026.Shareholders will receive audited consolidated financial statements for year ended Dec. 31, 2025.Meeting will vote on re-election of Ren Delin, Wu Yuting, Fu Lei.Board will seek mandate to set directors’ remuneration, reappoint Ernst & Young as auditor, set auditor fees.Resolutions include general mandates to issue shares up to 20% of issued share capital, repurchase shares up to 10%, extend issuance mandate by shares repurchased.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VIVA Biotech Holdings published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL4F6w14:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1576","01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629149015","title":"Viva Biotech publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2629149015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629149015?lang=en_us&edition=fundamental","pubTime":"2026-04-22 16:36","pubTimestamp":1776846966,"startTime":"0","endTime":"0","summary":"Viva Biotech issued its 2025 annual report, highlighting a return to growth in CRO activity supported by improving biopharma funding conditions and stronger China drug deal flow.AI-driven drug discovery expanded across operations, with AI-enabled work contributing about 12% of CRO revenue and covering 196 projects for 73 customers.CDMO unit Langhua Pharmaceutical improved profitability through product mix changes, with 2 commercial-stage programs expected to launch in 2026 and 2027.Investment and incubation business monetized several exits, generating RMB 150.5 million investment income in 2025.Board did not recommend a final dividend for year ended Dec. 31, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VIVA Biotech Holdings pub","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL41z8Sq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","01873","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629198082","title":"Viva Biotech hosts webinar on AI and flow chemistry in drug synthesis scale-up","url":"https://stock-news.laohu8.com/highlight/detail?id=2629198082","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629198082?lang=en_us&edition=fundamental","pubTime":"2026-04-21 17:58","pubTimestamp":1776765513,"startTime":"0","endTime":"0","summary":"Viva Biotech hosted its “AI x Flow Chemistry: From Bench to Business - Academic and Industry Perspectives” webinar on April 21, 2026.Viva positioned flow chemistry as a scalable, integrated capability across discovery and manufacturing, citing internal case studies that delivered more than 20 g/day of a photochemical scaffold, 80 g/day of crude difluoromethyl intermediate, and 1,000 kg via a continuous-flow Curtius rearrangement within two months.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL3zWvrt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1576","01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197440022","title":"Viva Biotech Files March 2026 Monthly Return: Share Capital Stable, 15.92 Million Options Outstanding","url":"https://stock-news.laohu8.com/highlight/detail?id=1197440022","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197440022?lang=en_us&edition=fundamental","pubTime":"2026-04-09 15:40","pubTimestamp":1775720441,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings submitted its Monthly Return for Equity Issuer to Hong Kong Exchanges and Clearing Limited for the period ended 31 March 2026. Key takeaways are as follows: 1. Authorised Share...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111816651","title":"Viva Biotech Reports Stable Share Capital Structure for January 2026; 4.42 Million Post-IPO Options Lapse","url":"https://stock-news.laohu8.com/highlight/detail?id=1111816651","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111816651?lang=en_us&edition=fundamental","pubTime":"2026-04-09 15:20","pubTimestamp":1775719239,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings disclosed its Monthly Return for Equity Issuers for the period ended 31 January 2026, confirming a steady capital structure and compliance with Hong Kong Stock Exchange...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivabiotech.com","stockEarnings":[{"period":"1week","weight":-0.0577},{"period":"1month","weight":-0.2222},{"period":"3month","weight":-0.3636},{"period":"6month","weight":-0.3066},{"period":"1year","weight":-0.1145},{"period":"ytd","weight":-0.1833}],"compareEarnings":[{"period":"1week","weight":-0.0089},{"period":"1month","weight":0.02},{"period":"3month","weight":-0.0067},{"period":"6month","weight":-0.0069},{"period":"1year","weight":0.1163},{"period":"ytd","weight":0.0296}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"VIVA Biotech Holdings is an investment holding company. The Company has two segments. The Drug Discovery Services segment provides structure-based drug discovery services to biotech and pharmaceutical clients for preclinical innovative drug development. The Contract Design and Manufacturing (CDMO) and Commercialization Services segment is engaged in contract development and manufacturing services for small molecule Active Pharmaceutical Ingredients (APIs) and intermediates, as well as the trading of APIs, intermediates and finished products. The Company conducts business primarily in the United States, China, Europe and other regions.","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.080145},{"month":2,"riseRate":0.285714,"avgChangeRate":0.018359},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.001599},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.030961},{"month":5,"riseRate":0.571429,"avgChangeRate":0.192779},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.034299},{"month":7,"riseRate":0.714286,"avgChangeRate":0.010126},{"month":8,"riseRate":0.428571,"avgChangeRate":0.041644},{"month":9,"riseRate":0.285714,"avgChangeRate":0.021762},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.044725},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.040545},{"month":12,"riseRate":0.571429,"avgChangeRate":0.026236}],"exchange":"SEHK","name":"VIVA BIOTECH","nameEN":"VIVA BIOTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VIVA BIOTECH(01873),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest VIVA BIOTECH(01873) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"VIVA BIOTECH,01873,VIVA BIOTECH股票,VIVA BIOTECH股票老虎,VIVA BIOTECH股票老虎国际,VIVA BIOTECH行情,VIVA BIOTECH股票行情,VIVA BIOTECH股价,VIVA BIOTECH股市,VIVA BIOTECH股票价格,VIVA BIOTECH股票交易,VIVA BIOTECH股票购买,VIVA BIOTECH股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VIVA BIOTECH(01873),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest VIVA BIOTECH(01873) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}